Cytomegalovirus InfectionsLiver TransplantationCytomegalovirusMuromegalovirusTransplantation, HomologousLiver DiseasesLiving DonorsLiver FailureKidney TransplantationGanciclovirGraft SurvivalGraft RejectionBone Marrow TransplantationTissue DonorsLiverLiver CirrhosisLiver NeoplasmsCytomegalovirus RetinitisImmunosuppressive AgentsCytomegalovirus VaccinesPostoperative ComplicationsTreatment OutcomeHematopoietic Stem Cell TransplantationHeart TransplantationAntiviral AgentsLung TransplantationRetrospective StudiesHerpesviridae InfectionsTime FactorsOrgan TransplantationEnd Stage Liver DiseaseTissue and Organ ProcurementLiver Failure, AcuteTransplantationTransplantation, AutologousImmunosuppressionWaiting ListsDNA, ViralAntibodies, ViralRecurrenceBiliary AtresiaFoscarnetTransplantation ImmunologyHepatectomyStem Cell TransplantationLiver Function TestsPancreas TransplantationLiver RegenerationCarcinoma, HepatocellularPortal VeinTacrolimusImmediate-Early ProteinsAntigens, ViralImmunocompetenceHepatic ArteryTransplantation ConditioningHepatic VeinsFollow-Up StudiesLiver CirculationPregnancy Complications, InfectiousTransplantsRisk FactorsVirus ReplicationSurvival RateDonor SelectionVirus ActivationBiliary Tract DiseasesGraft vs Host DiseaseImmunocompromised HostFatty LiverViral ProteinsOpportunistic InfectionsCyclosporinePolymerase Chain ReactionIslets of Langerhans TransplantationCadaverInfant, NewbornCold IschemiaCell TransplantationCholangitis, SclerosingPostoperative PeriodCells, CulturedHistocompatibility TestingTransplantation ChimeraProspective StudiesBile DuctsTissue and Organ HarvestingSurvival AnalysisAnastomosis, SurgicalPatient SelectionFibroblastsViral Matrix ProteinsRoseolovirusAcute DiseaseAmyloid Neuropathies, FamilialViremiaHeart-Lung TransplantationTransplantation, IsogeneicFatal OutcomeMice, Inbred BALB C